REV-ERB agonist is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-08-13. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
=== Supercritical fluid in power generation === The efficiency of a heat engine is ultimately dependent on the temperature difference between heat source and sink (Carnot cycle). To improve efficiency of power stations the operating temperature must be raised. Using water as the working fluid, this takes it into supercritical conditions. Efficiencies can be raised from about 39% for subcritical operation to about 45% using current technology. Many coal-fired supercritical steam generators are operational all over the world. Supercritical carbon dioxide is also proposed as a working fluid, which would have the advantage of lower critical pressure than water, but issues with corrosion are not yet fully solved. One proposed application is the Allam cycle. Supercritical water reactors (SCWRs) are proposed advanced nuclear systems that offer similar thermal efficiency gains.
==== Use in diagnostics ==== First cTnI and later cTnT were originally used as markers for cardiac cell death. Both proteins are now widely used to diagnose acute myocardial infarction (AMI), unstable angina, post-surgery myocardium trauma and some other related diseases with cardiac muscle injury. Both markers can be detected in patient's blood 3–6 hours after onset of the chest pain, reaching peak level within 16–30 hours. Elevated concentration of cTnI and cTnT in blood samples can be detected even 5–8 days after onset of the symptoms, making both proteins useful also for the late diagnosis of AMI.
==== Medical evacuations ==== Due to the destruction of Gaza's healthcare system, medical evacuation is necessary for access to specialized treatment unavailable in the Gaza Strip. Evacuation planning for children with medical concerns such as cancer out of Gaza and to continue treatment began in mid-October 2023, with discussions and negotiations among the United States, Egypt, Israel and Palestinian health officials along with World Health Organization and St. Jude Children's Research Hospital representatives. Many families and officials involved in Gaza have described a difficult process with damage to transportation avenues and communication networks causing many to miss crossing or pick-up times, while others were not allowed to evacuate with their children. After repeated airstrike damage and lack of fuel at least two dozen premature babies were evacuated out of Gaza hospitals to Egypt to continue the specialized care they needed. Those that were evacuated were suffering from life-threatening conditions including dehydration, vomiting, hypothermia and sepsis due to the lack of medicine and fuel. Injured children were also evacuated with Turkey offering treatment and resources to at least two groups of children that were receiving intensive care treatment. It was reported in early March 2024, that about 300 children had been evacuated to Qatar with the majority being wounded and needing treatment but some being parents or a supporter.
The brown bear has a hump between its shoulders, a distinction from other bear species. This hump is formed by large muscles, allowing for a wide range of motion, which the bear mainly uses to put pressure on the soil as it digs for food. The bison also has a hump between its shoulders, made almost entirely of muscle and supported by long skeletal spines. The bison hump's purpose is to hold up the animal's large head, and also enables the animal to use its head as a snow shovel in the winter, swinging it side to side with its hump muscles. Such foraging behavior sets the bison apart from other ungulates, which typically use their feet to scrape away snow. Moose, similarly, have a shoulder hump of muscle that is necessary to hold up their large head and, in males, antlers.
Sources: en.wikipedia.org
In some part of South China, soups (Chinese: 湯/汤 tāng) are served between the cold dishes and the main dishes. In other parts of China, soups are served between the main dish and staple foods, before desserts or fruit salad. There are many traditional Chinese soups, such as wonton soup, herbal chicken soup, hot and sour soup, winter melon soup, and so on.
Belarus Governorate (Belorussian Gubernya, 1802) divided into Vitebsk and Mogilev Gubernya Bratslav Governorate (or Bratslav uyezd, see Podolia Governorate) Chernigov Governorate Izyaslav Governorate Yekaterinoslav Governorate/Novorossiya Governorate (1764) Kiev Governorate (1708) Lithuania Governorate (1795), later split into Lithuania-Grodno Governorate and Lithuania-Vilna Governorate, the last one later split into Vilna and Kovno Governorates Minsk Governorate (1793) Mogilev Governorate (1772) Podolia Governorate (1773) Polotsk Governorate Pskov Governorate Slonim Governorate (1795) (several months after creation connected to Lithuania Governorate in and split off from it in 1801 as Lithuania-Grodno Governorate) Volhynia Governorate (1793) After the Congress of Vienna in 1815, the Russian Empire created a separate entity called Congress Poland out of some of the above governorates. See administrative division of Congress Poland for details. Territories in the Russian partition which were not incorporated into Congress Poland were officially known as the Western Krai, and in Poland as the taken lands (Polish: ziemie zabrane). The Western Krai comprised the following lands of the Commonwealth:
== Absorption, metabolism and excretion == Retinyl esters from animal-sourced foods (or synthesized for dietary supplements for humans and domesticated animals) are acted upon by retinyl ester hydrolases in the lumen of the small intestine to release free retinol. Retinol enters enterocytes by passive diffusion. Absorption efficiency is in the range of 70 to 90%. Humans are at risk for acute or chronic vitamin A toxicity because there are no mechanisms to suppress absorption or excrete the excess in urine. Within the cell, retinol is there bound to retinol binding protein 2 (RBP2). It is then enzymatically re-esterified by the action of lecithin retinol acyltransferase and incorporated into chylomicrons that are secreted into the lymphatic system. Unlike retinol, β-carotene is taken up by enterocytes by the membrane transporter protein scavenger receptor B1 (SCARB1). The protein is upregulated in times of vitamin A deficiency. If vitamin A status is in the normal range, SCARB1 is downregulated, reducing absorption. Also downregulated is the enzyme beta-carotene 15,15'-dioxygenase (formerly known as beta-carotene 15,15'-monooxygenase) coded for by the BCMO1 gene, responsible for symmetrically cleaving β-carotene into retinal. Absorbed β-carotene is either incorporated as such into chylomicrons or first converted to retinal and then retinol, bound to RBP2. After a meal, roughly two-thirds of the chylomicrons are taken up by the liver with the remainder delivered to peripheral tissues. Peripheral tissues also can convert chylomicron β-carotene to retinol.
=== Softmaxxing === "Softmaxxing" is a subset of looksmaxxing that refers to non-invasive and simple practices used to achieve minor improvements to one's appearance. These include skincare, grooming, clothing choices, and general fitness such as weight management and exercise. Additional less conventional practices are also included in the scope of softmaxxing; popular examples include "mewing", which involves suctioning one's tongue to the roof of the mouth with the intention of an improved jaw and facial structure, and "NoFap", where one abstains from masturbation for perceived physical and mental benefits. Such practices come up more often in looksmaxxing discourse due to their niche nature. Practices associated with softmaxxing were previously popularized among men by magazines such as GQ, Esquire, and Men's Health, which share skincare and hairstyle advice.
=== Single-nucleotide polymorphisms === A single-nucleotide polymorphism (SNP) is a genetic variation in which a genome sequence is altered by a single nucleotide (A, T, C or G). NET proteins with an altered amino acid sequence (more specifically, a missense mutation) could potentially be associated with various diseases that involve abnormally high or low plasma levels of norepinephrine due to altered NET function. NET SNPs and possible associations with various diseases are an area of focus for many research projects. There is evidence suggesting a relationship between NET SNPs and various disorders such as ADHD psychiatric disorders, postural tachycardia and orthostatic intolerance. The SNPs rs3785143 and rs11568324 have been related to attention-deficit hyperactivity disorder. Thus far, however, the only confirmed direct association between a SNP and a clinical condition is that of the SNP, Ala457Pro, and orthostatic intolerance. Thirteen NET missense mutations have been discovered so far.
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.